testinal tract, hepatic, hindlimb, and renal recovery of CO 2 in vivo. J Appl Physiol 89: [2000][2001][2002][2003][2004][2005][2006] 2000.-Whole body oxidative rates of labeled substrates are often measured by collecting expired air and determining the amount of labeled CO 2 that is produced. However, the CO 2 produced may not be completely recovered under all circumstances, and there is a wide variation in values reported under different experimental conditions (ϳ50-100%). The potential contribution of specific organs to this variation has not been defined. In vivo studies using healthy, postabsorptive, multicatheterized conscious canines were conducted to determine gastrointestinal tract, hepatic, hindlimb, and renal recoveries of NaH 14 CO 3 during a 180-min constant infusion [0.022
THE USE AND MEASUREMENT of carbon isotopes have been critical to the understanding of nutrient utilization. Protein, carbohydrate, and lipid homeostasis has been assessed under a variety of conditions using 14 C-and 13 C-labeled substrates of leucine, glucose, and palmitate, respectively. These labeled substrates liberate labeled CO 2 when they are oxidized. Thus the whole body oxidative rate of these labeled substrates can be measured by collecting expired air and determining the amount of labeled CO 2 produced.
However, previous studies have suggested that the CO 2 produced is not completely recovered under all circumstances. Recovery of CO 2 has been assessed under a variety of conditions using different experimental techniques, and there is a wide variation in the reported values (ϳ50-100%) (1-6, 10, 13, 15, 22, 24, 27-29) . A portion of the incomplete recovery has been attributed to fixation of CO 2 through conversion of pyruvate to oxaloacetate (4, 7, 26, 28) . Hence, organs with increased enzymatic activity for this metabolic process, such as the liver, should also have lower rates of CO 2 recovery. However, there are no published reports on the tissues and organs responsible for this incomplete recovery. Furthermore, it is unclear how much of the variation in reported CO 2 recoveries is due to differences in experimental conditions and techniques vs. the portion due to fixation of CO 2 .
Therefore, in vivo studies with multicatheterized canines were conducted to elucidate the contributions of the liver, gastrointestinal tract (gut), muscle, and kidneys to the fixation of CO 2 and to test the hypothesis that the loss of CO 2 is greater in organs that are involved in gluconeogenesis. Because there are no published data that examine the contribution of these organs to CO 2 fixation in a comprehensive manner in vivo, appropriate fixation correction factors for measurements of organ oxidation of a 14 C-or 13 C-labeled substrate are unavailable. Therefore, studies also were conducted to determine the importance of appropriate correction factors for each organ that was tested.
MATERIALS AND METHODS
Animals and surgical procedures. Seven mongrel dogs [20.6 Ϯ 0.8 (SE) kg] of either sex were used in this study. Approximately 17 days before the metabolic study, a midline laparotomy was performed under general anesthesia, as previously described (31) , to place chronic catheters in the left femoral artery, right common iliac vein, hepatic vein, portal vein, and, in two cases, the left renal vein. Doppler flow probes (Instrumentation Development Laboratory, Houston, TX) were placed around the left external iliac and renal arteries for the measurement of blood flow (12) . After placement, the catheters were filled with heparinized saline (200 U/ml), and the free ends were knotted and placed in a subcutaneous pocket, along with the leads of the Doppler flow probes, until the study day. A tracheostomy was performed for the collection of breath, as previously described (31) .
After surgery, each dog was allowed to recover for ϳ17 days before the study began. All animals were assessed to be in good health before they were studied, using the following criteria: 1) consumption of daily ration for 3 days before study, 2) normal stools, 3) blood leukocyte count Ͻ18,000/ mm, and 4) hematocrit Ͼ36%. The dogs had free access to water and were fed a meat and chow diet consisting of 31% protein, 52% carbohydrate, 11% fat, and 6% fiber.
After an overnight fast, the catheters and flow cuff leads were removed from the subcutaneous pocket under local anesthesia (2% lidocaine; Xylocaine, Astra Pharmaceutical, Worcester, MA), and the catheters were flushed with normal saline. The dogs were placed in a Pavlov harness and allowed to rest for 1 h. During this period, an 18-gauge angiocatheter was inserted percutaneously into the cephalic vein for the infusion of NaH 14 CO 3 and indocyanine green. Infusion of heparinized saline (1 U/ml) was started via the arterial line to replace the sampled blood volume and to maintain arterial catheter patency. Finally, a 7-Fr tracheostomy tube (Shiley, Irvine, CA) was inserted into the trachea for collection of expired air.
Experimental design. Each study ( Fig. 1 ) consisted of an initial 15-min bolus tracer decay period (Ϫ15 to 0 min), a 90-min equilibration period (0 to 90 min), and a 90-min sampling period (90 to 180 min). A stock solution of isotope was made by dissolving NaH 14 CO 3 (ICN Biomedicals, Irvine, CA) in 0.1 N NaOH (25 Ci/ml). The infusate for the constant infusion portion of the study was made immediately before the experiment by diluting stock solution with normal saline and placing it in infusion syringes. A portion of the infusate was sampled before and immediately after the study and counted for radioactivity. Radioactivity in the samples of infusate was not different between these two sampling times. Before bolus tracer injection, a baseline blood sample was taken. A bolus injection of NaH 14 CO 3 (1.76 Ϯ 0.16 Ci/kg) was administered over 10 s to initiate the study. Subsequently, arterial blood was sampled at time (t) ϭ Ϫ15 (immediately), Ϫ13, Ϫ11, Ϫ9, Ϫ6, Ϫ3, and 0 min. The constant infusion of NaH 14 CO 3 (0.022 Ϯ 0.002 Ci ⅐ kg Ϫ1 ⅐ min Ϫ1 ) was initiated at t ϭ 0 min.
At t ϭ 60 min and continuing through the sampling period, the tracheostomy tube was connected directly to a respiration cart (Amteck, Pittsburgh, PA) for the determination of whole body CO 2 production (V CO 2 ). During this period, breath and blood samples were collected every 15 min during the first hour and every 30 min during the second hour for the determination of blood and breath 14 CO 2 . Simultaneously, blood flow measurements were made at these same time points.
Collection and processing of samples. Expired air for the measurement of 14 CO 2 was collected into a 30-liter Douglas bag over a 2-min period. To trap CO 2 for scintillation counting, air in the Douglas bag was immediately bubbled through a solution of 2 ml absolute ethanol, 0.25 mg phenolphthalein, and 50 l hyamine hydroxide (methylbenzethonium hydroxide; Sigma Chemical, St. Louis, MO), until the indicator turned from purple to clear. The trapping vials were prepared in one large batch, from which a subset was titrated with 1 N HCl to determine the microequivalents of CO 2 that would be extracted by the basic solution. After trapping the expired CO 2 , 2 ml of 0.5 N NaOH and 19 ml of scintillation fluid [EcoLite (ϩ) , ICN Biomedicals] were immediately added. The samples were left in the dark for 4 days to minimize chemiluminescence and were then counted in a liquid scintillation counter (LS-2800, Beckman Instruments, Palo Alto, CA).
Before the study, 23-ml scintillation vials were prepared as diagrammed in Fig. 2 . Each vial contained 1 ml of 6 N HCl, and the vial was capped with a rubber stopper, to which a plastic well containing chromatography paper (3 mm, Whatman, Maidstone, UK) was attached. After closure of the rubber stopper, 200 l of hyamine hydroxide were added to the vial well using an 18-gauge needle and an air displacement pipette. The chromatography paper absorbed the hyamine hydroxide. In addition, 2 ml of air were removed from the scintillation vial using a syringe with an 18-gauge needle.
Heparinized syringes were used to collect blood from the sampling catheters. A 1-ml aliquot of each blood sample was immediately transferred through the rubber stopper and placed into the 6 N HCl at the bottom of the scintillation vial using an 18-gauge needle attached to an air displacement pipette (Fig. 2) . The samples were allowed to stand overnight at room temperature for complete liberation of CO 2 , after which the rubber stoppers were removed from each vial. The chromatography paper and the well of each sample were placed into another scintillation vial, which contained 2 ml of 0.5 N NaOH (1,000 mol). Twenty-one milliliters of scintillation fluid were added to each vial, and, after 4 days in darkness, the samples were placed into a liquid scintillation counter for radioactive determination.
Three milliliters of arterial blood were directly transferred from the syringe to Vacutainer tubes containing EGTA and reduced glutathione (CAT-A-kit, Upjohn Pharmaceuticals, Kalamazoo, MI) for determination of plasma catecholamine levels by HPLC (2) . The remainder of the blood was transferred to Venoject tubes containing 15 mg Na 2 -EDTA (Terumo Medical, Elkton, MD). Samples were thoroughly mixed by inversion and centrifuged in a refrigerated (4°C) desktop centrifuge (Beckman Instruments) at 3,000 rpm. The plasma collected was immediately placed on ice. A 2.5-ml aliquot of arterial plasma was transferred to separate tubes and stored at Ϫ70°C for later determination of insulin and cortisol. Immunoreactive insulin was measured using the Sephadex bound antibody (Pharmacia, Piscataway, NJ) procedure (30) . Plasma cortisol was measured using the Clinical Assays Gammacoat radioimmunoassay kit (Travenol-Gentec, Cambridge, MA). Plasma glucose was assayed using a glucose analyzer (model II, Beckman Instruments, Fullerton, CA).
Blood flow to the splanchnic bed was estimated using the cardiogreen extraction method of Leevy et al. (17) . A continuous infusion of indocyanine green (ICG; 0.1 mg ⅐ m Ϫ2 ⅐ min Ϫ1 ) (Becton Dickinson, Cockeysville, MD) was started at t ϭ 0 min, and plasma ICG levels were measured spectrophotometrically at 810 nm in samples from the artery and hepatic vein. This method assumes that the ICG dye is extracted by hepatic parenchymal cells in a nonsaturable manner. Based on our experience with Doppler flow probes, we assumed that 80% of the total flow to the liver was portal in origin and that the remaining 20% was from the hepatic artery.
Calculations. Decay curves were analyzed by performing a multiple-regression ANOVA on the curve following the bolus injection to test for the best fit (Statistical Analysis System for Windows, 1996 Release 6.12, SAS Institute, Cary, NC). One-, two-, three-, and four-exponential models were tested. No additional advantage was noted beyond a two-exponential curvilinear model. Therefore, this model was used to analyze each individual study, and the results are reported as averages of these analyses.
It was assumed that the first component of the curve was the result of tracer mixing (26) . When testing to find the best fit for the second component, no additional advantage was noted when time points less than Ϫ13 min were removed from the second-order exponential. The pretracer infusion y-intercept of the second component line (Ϫ13 to 0 min) was determined by extrapolating the calculated slope to Ϫ15 min. The Ϫ15-min y-intercept was used to establish pool size.
Tracer steady state during the sampling period for recovery of CO 2 was achieved during the last 90 min, as indicated by a slope not significantly different from zero. The time points during this steady state period were averaged for each individual experiment. All results are reported as means Ϯ SE.
The percent recoveries of CO 2 for gut, hindlimb, and kidney were calculated as the radioactivity per milliliter of venous blood (dpm ven ) divided by the radioactivity per milliliter of arterial blood (dpm art ) multiplied by 100% %CO 2 organ recovery ϭ ͑dpm ven /dpm art ͒ ϫ 100%
(1)
The percent recovery of CO 2 for the liver was calculated as the radioactivity per milliliter of hepatic venous blood (dpm hv ) divided by the sum of the radioactivity per milliliter of portal venous blood ( A plastic well containing chromatography paper and 200 l of hyamine hydroxide was suspended above 1 ml of 6 N HCl in scintillation vials before the study day. The vial, which was made airtight with a rubber stopper, had 2 ml of air evacuated to create a slight negative pressure within the vial. 1 ml of blood was pipetted through an 18-gauge needle into the HCl solution, and the samples were allowed to stand overnight so that the CO 2 could be liberated from the blood and absorbed by the hyamine hydroxide. The next day, the chromatography paper and well were transferred to a second scintillation vial containing 2 ml of 0.5 N NaOH. Scintillation fluid was then added to fill the vial. The samples were counted for radioactivity after 4 days in darkness.
Percent whole body recovery of CO 2 
RESULTS
The dogs were in a normal overnight-fasted state, as was reflected by their circulating glucose and metabolic hormone concentrations. Arterial glucose concentrations remained constant throughout the time course of each study (108.8 Ϯ 1.8 mg/dl). Insulin (10.5 Ϯ 1.3 U/ml), cortisol (6.0 Ϯ 0.4 g/dl), epinephrine (197 Ϯ 43 pg/ml), and norepinephrine (180.8 Ϯ 18.7 pg/ml) also remained steady for all dogs.
Pool size for the distribution of the CO 2 tracer was determined from the decay curve of the bolus tracer infusion (Fig. 3A, Table 1 ). The best-fit curve after the bolus tracer injection contained two components. Slopes of the rapidly perfused pool vs. the central pool were Ϫ4,626 Ϯ 1,391 vs. Ϫ244 Ϯ 53 dpm/min, respectively. It was assumed that the first component, which lasted ϳ2 min, represented the mixing phase for the rapidly perfused tissues. The second component, assumed to represent the central or primary pool, was measured from Ϫ13 to 0 min. The data fit this line with a correlation coefficient (r) of 0.9998. The pool size was calculated to be ϳ80% of the total body pool at 16.0 Ϯ 1.7 liters.
Steady state for the recovery data was achieved during the final 90 min, as illustrated in Fig. 3B . During this steady-state period, whole body CO 2 recovery was 97.2 Ϯ 6.7% (Fig. 4) . V CO 2 , based on measurements of tracer dilution, was 351 Ϯ 18 mol⅐kg Ϫ1 ⅐min
Ϫ1
. This compared favorably with V CO 2 measured by the respiration cart, which was 377 Ϯ 28 mol⅐kg Ϫ1 ⅐min
. Furthermore, the similarities of these two measures of V CO 2 for the seven dogs tested are demonstrated by their significant correlation (r ϭ 0.69) as well as the closeness of their relationship to identity. With perfect identity, the equation describing the relationship of these two measures would have a slope of 1.0 and a y-intercept of zero. However, the actual relationship was calculated to have a slope of 1.08 and a y-intercept of 2 mol ⅐ kg Ϫ1 ⅐ min
. During the steady-state period, blood flows through the tissues of the gastrointestinal tract, liver, hind- Values are means Ϯ SE of 7 studies. dpm, Disintegrations per minute. The best-fit curve after the bolus tracer injection contained 2 components, with the first representing the mixing phase and the second (Ϫ13 to 0 min) representing the primary pool. Pool size was calculated by extrapolating the slope of the best-fit line from the primary pool back to the preisotope infusion y-intercept (Ϫ15 min).
limb, and kidney were 587 Ϯ 32, 734 Ϯ 46, 205 Ϯ 10, and 186 Ϯ 5 ml/min, respectively. Radioactivity in each milliliter of blood was between 1,670 and 1,770 dpm, and specific activities for CO 2 within the portal, hepatic, femoral, and renal veins were 75 Ϯ 20, 76 Ϯ 19, 70 Ϯ 16, and 73 Ϯ 14 dpm/mol, respectively. Recoveries across the liver, gastrointestinal tract, leg, and kidney were 99.9 Ϯ 1.3, 98.0 Ϯ 1.4, 96.7 Ϯ 2.6, and 99.9 Ϯ 2.1%, respectively (Fig. 4) . V CO 2 by the gastrointestinal tract, liver, hindlimb, and kidney, as determined by tracer dilution measurements, were 12.4 Ϯ 0.7, 15.4 Ϯ 0.9, 4.6 Ϯ 0.2, and 3.9 Ϯ 0.1 mmol/min, respectively.
DISCUSSION
There is considerable diversity reported for the measurements of CO 2 recovery in vivo. The aim of the present study was to determine CO 2 recovery across several major organs in addition to whole body CO 2 recovery in vivo. The data obtained from conscious, postabsorptive canines in this study suggest that whole body CO 2 recovery was slightly Ͻ100%. This is supported by the fact that measurements of whole body V CO 2 were similar using either an indirect calorimeter or tracer dilution. Furthermore, recovery across the liver, gastrointestinal tract, leg, and kidney were also slightly Ͻ100%. Although V CO 2 was considerably different between the four organs measured (liver Ͼ gastrointestinal tract Ͼ hindlimb Ͼ kidney), there were no significant differences between the gluconeogenic and nongluconeogenic organs in terms of CO 2 recovery. These data suggest that only minor corrections for incomplete recovery of CO 2 are needed when measuring oxidation of substrates across these organs.
Whereas CO 2 is the end product of substrate oxidation and is normally eliminated in the breath, there is a portion that theoretically can be reincorporated or "fixed" into macromolecules. Most higher animals have the ability to fix CO 2 as the carboxyl carbon of oxaloacetate. For example, the enzyme pyruvate carboxylase combines CO 2 , ATP, and pyruvic acid in the formation of oxaloacetic acid, ADP, and inorganic phosphate. In a net sense, no additional glucose is formed from CO 2 fixation, as another CO 2 molecule is lost in the subsequent reactions when oxaloacetate is converted to phosphoenolpyruvate and, ultimately, glucose. However, even though there is not a net accumulation of total CO 2 , labeled CO 2 formed from substrate oxidation can be taken up on a net basis. The incorporation of labeled CO 2 molecules into glucose molecules has been used as a basis for the estimation of gluconeogenesis (7, 20, 23) .
The fact that CO 2 recovery was relatively high in the present study does not invalidate either the concept of CO 2 fixation or the aforementioned method of estimating gluconeogenesis. However, it does demonstrate the comparative magnitude of these events and suggests that CO 2 fixation would minimally impact measurements of substrate oxidation across the organs that were measured. A previous report of gluconeogenesis using radioactive bicarbonate infusion lead to similar conclusions (7) . In this previous study, the radioactivity associated with CO 2 in 1 ml of blood (ϳ180 dpm) was 10-fold greater than the simultaneous measurement of the radioactivity associated with glucose (ϳ18 dpm in 1 ml blood). This necessitates either special counting techniques for radioactivity, greater quantities of blood collection, or larger doses of radioactivity during bicarbonate infusion. Although most of the tracer decay in the present study could be attributed to either rapidly perfused tissues or a central pool, the existence of a very slowly perfused pool is possible. The rate of entry into this slowly perfused pool would be tremendously smaller than the rates of entry into the rapidly perfused and central pools, thereby making measurements for such a pool difficult. Taken together, these findings demonstrate that the pathway of CO 2 fixation is proportionally small compared with the overall disposition of CO 2 .
Although whole body CO 2 recovery in the present study approaches 100%, there is considerable variation in previously reported values. One potential factor that may contribute to this variation is that differing physiological conditions may increase fixation of CO 2 . Prevailing physiological factors, such as abnormal acidbase balance or a hormonal milieu that promotes gluconeogenesis, have been reported to have significant effects on CO 2 recovery (10, 21, 25) . If there were a perturbation that would result in a severalfold increase in the activity of enzymes that fix CO 2 , recovery measurements may be increased, supporting the notion that recovery needs to be assessed in each particular experimental setting. However, the magnitude of this increase would have to be very large. The dogs in the present study were in a postabsorptive state; thus a significant portion of glucose production would already be coming from events of gluconeogenesis. However, even if the events of gluconeogenesis and the pathways of CO 2 fixation were doubled from this postabsorptive state, our data would suggest that the measurement of fixed CO 2 would still be minimal.
Differences in experimental designs may result in variations of measured recovery of CO 2 . However, recovery does not appear to be species specific, as high and low recoveries have been reported in several spe-cies, including rats, dogs, and humans (1, 3-6, 9, 13, 14, 16, 22, 24, 27-29) . Furthermore, there does not appear to be a relationship between study duration and CO 2 recovery. Studies from 3 to 36 h in length have produced similar variability. Likewise, the recovery of CO 2 is not affected by the use of either stable ( 13 C) or radioactive ( 14 C) isotopes, by the use of primed vs. unprimed continuous infusions, or by the amount of isotope infused (infusion rates ranging from 1.8 to 30 Ci ⅐ kg Ϫ1 ⅐ min Ϫ1 have produced similar variation). Theoretically, the site of cellular oxidation or compartmentalization could play a significant role in the amount of CO 2 recovered. The incorporation of CO 2 into glucose via oxaloacetate or into urea via ureagenesis occurs within the mitochondria. [␣-
14 C]ketoisocaproate (KIC) is also oxidized within the mitochondria. In an experiment in which KIC was infused, secondary labeling of glucose and urea was similar, suggesting that mitochondrial compartmentalization did not exist (7) . This is in agreement with previous in vivo and in vitro studies that concluded there is an absence of compartmentalization within hepatic mitochondria (18, 19) . However, when either carbon-labeled KIC or bicarbonate was infused, mitochondrial 14 CO 2 was greater in the KIC group (7). This suggests that 14 CO 2 derived endogenously within the mitochondria (KIC) resulted in a greater mitochondrial 14 CO 2 specific activity than when derived exogenously outside the mitochondria (NaH 14 CO 2 ). Furthermore, incorporation of 14 CO 2 into glucose was ϳ50% greater in the KIC group. This result was similar to preliminary data from another laboratory (9) . Together, these data suggest that compartmentalization within the cell may make an impact when quantifying the oxidation of a substrate; however, the results from the present study suggest that these events may have negligible effects on the overall measurements of CO 2 recovery. CO 2 collection and measurement methods provide a likely basis for the variation in recoveries that have been reported. It is difficult to determine whether sample-processing errors were a factor in the discordant results of previous studies, and these errors could make significant contributions to decreased recoveries. For optimal assessment of whole body recovery, a system that accurately determines expiration of labeled CO 2 is necessary. In the present study, we collected and measured expired air continually via a permanent tracheostomy. This method assured that total V CO 2 was measured accurately and completely. Whereas a tracheostomy is not required for complete measurement of labeled V CO 2 , mechanical factors are a source of recovery error that must be assessed in each experimental situation.
Another potential methodology error relates to the complete "trapping" of CO 2 . The trapping process requires the formation of ionic bonds, which may dissociate. In the present experiments, excess base (1,000 mol NaOH) was added to the scintillation vials, after the CO 2 was trapped, to prevent dissociation. Laboratory experiments before the in vivo studies demonstrated that Ͼ500 mol of NaOH were required to decrease the loss of radioactivity over time (Fig. 5A) . Additional tests also demonstrated the importance of using greater volumes of scintillation fluid and decreasing the air volume within the scintillation vial to complete recovery of 14 CO 2 (Fig. 5B) . When a vial with radioactive CO 2 in scintillation fluid without excess base sat for several hours, radioactive counts decreased (Fig. 5C ). When the same scintillation vials were shaken to mix the phases of liquid and gas, radioactive counts increased significantly. Finally, ra- Fig. 5 . Importance of technique for 14 CO 2 recovery measurements. A: addition of NaOH blunts loss of 14 CO 2 . Differing molar amounts of NaOH (s, 20 mol; *, 200 mol; ϫ, 500 mol; } 750 mol; E, 1,000 mol) were added to 23-ml scintillation vials containing radiolabeled CO 2 (130,000 dpm) and 10 ml of scintillation fluid. Vials with Ͻ500 mol NaOH had decreased dpm as time progressed. B: increased scintillation fluid volume blunts loss of 14 CO 2 . Differing amounts of scintillation fluid (}, 10 ml; F, 15 ml; OE, 23 ml) were added to 23-ml scintillation vials containing radiolabeled CO 2 (120,000 dpm). With 10 ml of scintillation fluid, dpm decreased over time, but, as the amount of scintillation fluid was increased to fill the vial, dpm was maintained. C: CO 2 in scintillation fluid leaves the liquid phase and enters the gas phase when excess base is not present. NaH 14 CO 3 (130,000 dpm) was added to 23-ml scintillation vials containing 10 ml of scintillation fluid. 1,000 mol of NaOH were added ({, scintillation fluid ϩ NaOH) to one set of vials, and a second set had no NaOH added (E, scintillation fluid). After 14 h, both vials were shaken (S) and, after 17 h, vials in both groups were opened (O) for 5 min. In the group with NaOH, dpm did not decrease, and neither shaking nor opening altered the counts. When NaOH was not added, dpm decreased with time. When the vials without NaOH were shaken, dpm increased, suggesting that the CO 2 returned to the liquid scintillation layer. When the vial was left open for 5 min, dpm decreased, suggesting that the CO 2 was released into the surrounding atmosphere. dioactivity was irreversibly lost when the cover of the same vial was removed. Thus filling the vial with scintillation fluid is recommended to prevent CO 2 from moving into a layer of air above the fluid and away from the scintillate.
In conclusion, although there is considerable diversity in the measurements of CO 2 recovery in vivo, whole body CO 2 recovery was slightly Ͻ100% in the present study of conscious, postabsorptive canines. Furthermore, recoveries across the gastrointestinal tract, leg, liver, and kidneys also were near 100%. This suggests that corrections for incomplete recovery of CO 2 , when measuring oxidation of substrates across these organs under normal postabsorptive conditions, would be very minor.
